WallStreetZenWallStreetZen

AnalystsNarumi Nakagiri
Narumi Nakagiri's Stock Forecasts

Analyst Ranking
Bottom 46%
#2520 out of 4571 analysts
Average Return
+1.48%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good

Narumi Nakagiri's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merck & Co IncMRK
+20.15%$93.01$111.75
2022-07-06 -
2023-07-06
Buy

Narumi Nakagiri Analyst Color

Get additional color on Narumi Nakagiri's coverage of popular stocks

Narumi Nakagiri's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Amgen IncAMGN
2Strong Buy$320.00+16.81%Upgrades
4 months ago
Bristol Myers Squibb CoBMY
1Hold$54.00+22.89%Downgrades
6 months ago
Pfizer IncPFE
2Hold$38.00+48.32%Downgrades
a year ago
Merck & Co IncMRK
1Buy$102.00N/AUpgrades
2 years ago
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.